Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury

Journal of Neurotrauma

Volumn 15, Issue 6, 1998, Pages 399-409

  Pleines, Ulrike E ^a   Stover, John F ^a   Kossmann, Thomas ^a   Trentz, Otmar ^a   Morganti Kossmann, Maria C ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adhesion molecules; Blood brain barrier; SICAM 1; Traumatic brain injury

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADOLESCENT; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; CELL ADHESION; CELL MIGRATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; RECEPTOR UPREGULATION;

EID: 0031776012     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1998.15.399     Document Type: Article

References (61)

1. ALBELDA, S.M., SMITH, C.W., and WARD, P.A. (1994). Adhesion molecules and inflammatory injury. FASEB J. 8, 504-512.
2. ALOISI, F., BORSELLINO, G., SAMOGGIA, P., et al. (1992). Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci. Res. 32, 494-506.
3. BALDWIN, S.A., FUGACCI, I., BROWN, D.R., and SCHEFF, S.W. (1996). Blood-brain barrier breach following cortical contusion in the rat. J. Neurosurg. 85, 476-481.
4. BIAGAS, K.V., UHL, M.W., SCHIDING, J.K., NEMOTO, E.M., and KOCHANEK, P.M. (1992). Assessment of post-traumatic polymorphnuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treatment. J. Neurotrauma 9, 363-371.
5. BOWES, M.P., ZIVIN, J.A., and ROTHLEIN, R. (1993). Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119, 215-219.
6. BUDNIK, A., GREWE, M., GYUFKO, K., and KRUTMANN, J. (1996). Analysis of the production of soluble ICAM-1 molecules by human cells. Exp. Hematol. 24, 352-359.
7. CANNELLA, B., and RAINE, C.S. (1995). The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435.
8. CARLOS, T.M., and HARLAN, J.M. (1994). Leukocyte-endothelial adhesion molecules. Blood 84, 2068-2101.
9. CONNOLLY, E.S., WINFREE, C.J., SPRINGER, T.A., et al. (1996). Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. J. Clin. Invest. 97, 209-216.
10. CROSS, A.H., CANNELLA, B., BROSUAN, C.F., and RAINE, C.S. (1991). Hypothesis: Antigen-specific T cell prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination. J. Neuroimmunol. 33, 237-244.
11. DIAMOND, M.S., STAUNTON, D.E., DE FOUGEROLLES, A.R., et al. (1990). ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J. Cell. Biol. 111, 3129-3139.
12. DUSTIN, M.L., and SPRINGER, T.A. (1988). Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J. Cell. Biol. 107, 321-331.
13. DUVDEVANI, R., ROOF, R.L., FÜLÖP, Z., HOFFMAN, S.W., and STEIN, D.G. (1995). Blood-brain-barrier break-down and edema formation following frontal cortical contusion: Does hormonal status play a role? J Neurotrauma 12, 65-75.
14. FABRY, Z., WALDSCHMIDT, M.M., HENDRICKSON, D., et al. (1992). Adhesion molecules on murine brain microvascular endothelial cells: Expression and regulation of ICAM-1 and Lgp 55. J. Neuroimmunol. 36, 1-11.
15. FROHMAN, E.M., FROHMAN, T.C., DUSTIN, M.L., et al. (1989). The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: Relevance to intracerebral antigen presentation. J. Neuroimmunol. 23, 117-124.
16. GEARING, A.J., HEMINGWAY, I., PIGOLT, R., HUGHES, J., REES, A.J., and CASHMAN, S.J. (1992). Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance. Ann. NY Acad. Sci. 667, 324-331.
17. GREENWOOD, J. (1991). Mechanisms of blood-brain barrier breakdown. Neuroradiology 33, 95-100.
18. HOSHINO, S., KOBAYASHI, S., and NAKAZAWA, S. (1996). Prolonged and extensive IgG immunoreactivity after severe fluid-percussion injury in rat brain. Brain Res. 711, 73-83.
19. ISAKSSON, J., LEWEN, A., HILLERED, L., and OLSSON, Y. (1997). Up-regulation of intercellular adhesion molecule 1 in cerebral microvessels after cortical contusion trauma in a rat model. Acta Neuropathol 94, 16-20.
20. JANDER, S., HEIDENREICH, F., and STOLL, G. (1993). Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology 43, 1809-1813.
21. JENNETT, B., and BOND, M. (1975). Assessment of outcome after severe brain damage. Lancet 1, 480-484.
22. KOSSMANN, T., HANS, V., IMHOF, H.G., TRENTZ, O., and MORGANTI-KOSSMANN, M.C. (1996). Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713, 143-152.
23. KOSSMANN, T., STAHEL, P.F., LENZLINGER, P.M., et al. (1997). Interleukin-8 released into cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J. Cereb. Blood Flow Metab. 17, 280-289.
24. KUROIWA, T., TING, P., MARTINEZ, H., et al. (1985). The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol. 68, 122-129.
25. LIU, H.M., and STURNER, W.Q. (1988). Extravasation of plasma proteins in brain trauma. Forensic Sci. Int. 38, 285-289.
26. MANDI, Y., FARKAS, G., OCSOVSZKY, I., and NAGY, Z. (1995). Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: Beneficial effects in sepsis syndrome. Res. Exp. Med. 195, 297-307.
27. MATSUO, Y., ONODERA, H., SHIGA, Y., et al. (1994). Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656, 344-352.
28. MEYER, D.M., DUSTIN, M.L., CARRON, C.P. (1995). Characterization of soluble intercellular adhesion molecule-1 (sICAM-1) ectodomain as an inhibitor of lymphocyte function associated molecule-1 interaction with ICAM-1. J. Immunol. 155:3578-3584.
29. MORGANTI-KOSSMANN, M.C., LENZLINGER, P.M., HANS, V., et al. (1997). Production of cytokines following brain injury: Beneficial and deleterious for the damaged tissue. Mol. Psych. 2, 133-136.
30. NAGEL, T., RESNICK, N., ATKINSON, W.J., DEWEY, C.F., and GIMBRONE, M.A. (1994). Shear stress selectively up-regulates intercellular adhesion molecule-1 expression in cultured human cells. J. Clin. Invest. 94, 885-891.
31. ÖNAL, C., ÜNAL, F., TURANTAN, M.I., ÜZÜM, G., HASANGOGLU, A., and KAYNAR, M.Y. (1997). The effect of intraventricular albumin in experimental brain edema. Acta Neurochir. (Wien) 139, 661-669.
32. OHATA, K., and MARMAROU, A. (1992). Clearance of brain edema and macromolecules through the cortical extracellular space. J. Neurosurg. 77, 387-396.
33. OHATA, K., MARMAROU, A., and POVLISHOCK, J.T. (1990). An immunocytochemical study of protein clearance in brain infusion edema. Acta Neuropathol. 81, 162-177.
34. REIBER, H., and FELGENHAUER, K. (1987). Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin. Chim. Acta. 163, 319-328.
35. RIECKMANN, P., NÜNKE, K., BURCHHARDT, M., et al. (1993). Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J. Neuroimmunol. 47, 133-140.
36. RIECKMANN, P., MICHEL, U., ALBRECHT, M., BRÜCK, W., WÖCKEL, L., and FELGENHAUER, K. (1995a). Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neurosci. Lett. 186, 61-64.
37. RIECKMANN, P., MICHEL, U., ALBRECHT, M., BRÜCK, W., WÖCKEL, L., and FELGENHAUER, K. (1995b). Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J. Neuroimmunol. 60, 9-15.
38. RIECKMANN, P., WEBER, F., GUNTHER, A., et al. (1996). Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J. Neuroimmunol. 64, 193-200.
39. RÖSSLER, K., NEUCHRIST, C., KITZ, K., SCHEINER, O., KRAFT, D., and LASSMANN, H. (1992). Expression of leukocyte adhesion molecules at the human blood-brain barrier (BBB). Neurosci. Res. 31, 365-374.
40. ROSENBERG, G.A., KYNER, W.T., and ESTRADA, E. (1980). Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions. Am. J. Physiol. 238, F42-F49.
41. ROTHLEIN, R., DUSTIN, M.L., MARLIN, S.D., and SPRINGER, T.A. (1986). A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137, 1270-1274.
42. ROTHLEIN, R., MAINOLFI, E.A., CZAJKOWSKI, M., and MARLIN, S.D. (1991). A form of circulating ICAM-1 in human serum. J. Immunol. 147, 3788-3793.
43. SATOH, J., KASTRUKOFF, L.F., and KIM, S.U. (1991a). Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J. Neuropathol. Exp. Neurol. 50, 215-226.
44. SATOH, J., KIM, S.U., KASTRUKOFF, L.F., and TAKEI, F. (1991b). Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J. Neurosci. Res. 29, 1-12.
45. SCHOETTLE, R.J., KOCHANEK, P.M., MAGARGEE, M.J., UHL, M.W., and NEMOTO, E.M. (1990). Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J. Neurotrauma 7, 207-217.
46. SETH, R., RAYMOND, F.D., and MAKGOBA, M.W. (1991). Circulating ICAM-1 isoforms: Diagnostic prospects for inflammatory and immune disorders. Lancet 338, 83-84.
47. SHARIEF, M.K., NOORI, M.A., CIARDI, M., CIRELLI, A., and THOMPSON, E.J. (1993). Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J. Neuroimmunol. 43, 15-21.
48. SHIBAYAMA, M., KUCHIWAKI, H., INAO, S., YOSHIDA, K., and ITO, M. (1996). Intercellular adhesion molecule-1 expression on glia following brain injury: Participation of interleukin-1β. J. Neurotrauma 13, 801-808.
49. SIMMONS, D., MAKGOBA, M., and SEED, B. (1988). ICAM, an adhesion ligand of LFA-1 is homologous to the neural cell adhesion molecule NCAM. Nature 331, 624-627.
50. SMITH, C.W., MARLIN, S.D., ROTHLEIN, R., TOMAN, C., and ANDERSON, D.C. (1989). Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83, 2008-2017.
51. SOBEL, R.A., MITCHELL, M.E., and FONDREN, G. (1990). Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136, 1309-1316.
52. STAUNTON, D.E., MARLIN, S.D., STRATOWA, C., DUSTIN, M.C., and SPRINGER, T.A. (1989). Primary structure of intercellular adhesion molecule-1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin superfamily. Cell 52, 925-932.
53. STAUB, F., WINKLER, A., HABERSTOK, J., et al. (1996). Swelling, intracellular acidosis, and damage of glial cells. Acta Neurochir (Suppl) 66, 56-62.
54. STOCKER, R., BERNAYS, R., KOSSMANN, T., and IMHOF, H.G. (1995). Monitoring and treatment of acute head injury, in: The Integrated Approach to Trauma Care. Goris, R.J.A., and Trentz O. (eds), Springer Verlag: Berlin, pps. 197-210.
55. TENGVAR, C., and OLLSON, Y. (1982). Uptake of macro-molecules into neurons from a focal vasogenic cerebral edema and subsequent axonal spread to other brain regions. Acta Neuropathol. 57, 233-235.
56. VORBRODT, A.W., LOSSINSKY, A.S., WISNIEWSKY, H.M., et al. (1987). Ultrastructural observations on the transvascular route of protein removal in vasogenic brain edema. Acta Neuropathol. 66, 265-273.
57. WAKATSUKI, T., KIMURA, K., KIMURA, F., et al. (1995). A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell. Adhes. Commun. 3, 283-292.
58. WECKERLE, H. (1993). Lymphocyte traffic to the brain, in: The Blood Brain Barrier. Pardridge, W.N. (ed), Raven Press: NY, pps. 67-85.
59. ZHANG, R.L., CHOPP, M., LI, Y., et al. (1994). Anti-ICAM antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44, 1747-1751.
60. ZHUANG, J., SHACKFORD, S.R., SCHMOCKER, J.D., and ANDERSON, M.L. (1993). The association of leukocytes with secondary brain injury. J. Trauma 35, 415-422.
61. ZIMMERMAN, G.A., PRESCOTT, S.M., and MCINTYRE, T.M. (1992). Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol. Today 13, 93-100.